fsme-immun 0.5 ml inj. susp. s.c./i.m. pre-filled syr.
pfizer sa-nv - tick-borne encephalitis virus (inactivated) antigen - suspension for injection in pre-filled syringe - 0,5 ml - tick-borne meningoencephalitis virus (tbe) - encephalitis, tick borne, inactivated, whole virus
fsme-immun 0,25 ml junior inj. susp. s.c./i.m. pre-filled syr.
pfizer sa-nv - tick-borne encephalitis virus (inactivated) antigen - suspension for injection in pre-filled syringe - tick-borne meningoencephalitis virus (tbe) - encephalitis, tick borne, inactivated, whole virus
hexaxim suspension for injection
sanofi-aventis (malaysia) sdn. bhd. - diphtheria toxoid; filamentous haemagglutin ( fha ); haemophilus influenza type b conjugate; hepatitis b surface antigen purified; pertussis toxoid ( pt); poliomyelitis, trivalent, inactivated, whole virus; tetanus toxoid -
biofire diagnostics filmarray meningitisencephalitis (me) panel
biomerieux singapore pte. ltd. - microbiology - the filmarray meningitis/encephalitis (me) panel is a qualitative multiplexed nucleic acid-based in vitro diagnostic test intended for use with filmarray systems. the filmarray me panel is capable of simultaneous detection and identification of multiple bacterial, viral, and yeast nucleic acids directly from cerebrospinal fluid (csf) specimens obtained via lumbar puncture from individuals with signs and/or symptoms of meningitis and/or encephalitis. the filmarray me panel is indicated as an aid in the diagnosis of specific agents of meningitis and/or encephalitis and results are meant to be used in conjunction with other clinical, epidemiological, and laboratory data. results from the filmarray me panel are not intended to be used as the sole basis for diagnosis, treatment, or other patient management decisions. filmarray me panel is intended to be used in conjunction with standard of care culture for organism recovery, serotyping, and antimicrobial susceptibility testing.
infanrix hexa (thiomersal free)
glaxosmithkline australia pty ltd - pertussis filamentous haemagglutinin; poliovirus; tetanus toxoid; pertactin; pertussis toxoid; hepatitis b surface antigen recombinant; polyribose ribitol phosphate - haemophilus influenzae type b; diphtheria toxoid -
infanrix penta
glaxosmithkline australia pty ltd - poliovirus; pertactin; pertussis filamentous haemagglutinin; pertussis toxoid; diphtheria toxoid; hepatitis b surface antigen recombinant; tetanus toxoid -
infanrix-hexa
tetanus toxoid; diphtheria toxoid; polyribose ribitol phosphate - haemophilus influenzae type b; poliovirus; pertactin; pertussis toxoid; hepatitis b surface antigen recombinant; pertussis filamentous haemagglutinin -
imojev® powder and diluent for suspension for injection
zuellig pharma pte. ltd. - japanese encephalitis virus (live, attenuated, recombinant) - injection, powder, lyophilized, for suspension - 4.0-5.8 log pfu/dose - japanese encephalitis virus (live, attenuated, recombinant) 4.0-5.8 log pfu/dose
ixiaro suspension for injection 0.5ml in pre-filled syringe
aenon pharmaceuticals sea pte. ltd. - japanese encephalitis virus strain sa₁₄-14-2 (inactivated) - injection, suspension - 6 μg/0.5 ml - japanese encephalitis virus strain sa₁₄-14-2 (inactivated) 6 μg/0.5 ml
imovax rabies powder for suspension
sanofi pasteur limited - rabies vaccine inactivated (human diploid-cell culture) - powder for suspension - 2.5unit - rabies vaccine inactivated (human diploid-cell culture) 2.5unit - vaccines